Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Relay Therapeutics Inc
About RLAY
Relay Therapeutics, Inc. is a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients living with cancer and genetic disease. The Company's Dynamo platform integrates an array of computational and experimental approaches designed to drug protein targets that have previously been intractable or inadequately addressed. The Company's lead clinical asset, zovegalisib (RLY-2608), is the pan-mutant selective PI3Ka inhibitor to enter clinical development and is currently in a Phase 3 clinical trial (ReDiscover-2) in HR+/HER2- metastatic breast cancer. Zovegalisib is also being investigated in a group of genetic disease indications called PI3Ka-driven vascular anomalies. Its pipeline also includes programs for NRAS-driven solid tumors and Fabry disease.
Find out what a historical investment in Relay Therapeutics Inc would be worth today using our RLAY stock calculator.
Market Capitalisation
$3.13B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
4.7M
High today
$14.54
Low today
$12.93
Open price
$14.54
52-week high
$17.47
52-week low
$2.98
Ready to start your investing journey with Stake?
Open an accountHow do I buy RLAY shares in Australia?
Buying RLAY shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Relay Therapeutics Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in RLAY
What is the ticker symbol of Relay Therapeutics Inc?
The ticker symbol for Relay Therapeutics Inc is RLAY.
How much is one share of RLAY?
One share of RLAY is valued at $13.15 as of 05 June 2026.
What is the market capitalisation of Relay Therapeutics Inc RLAY?
As of 05 June 2026 Relay Therapeutics Inc has a market cap of $3.13B.
What is the 52-week high for Relay Therapeutics Inc stock?
The Relay Therapeutics Inc 52-week high stock price is $17.47.
What is the 52-week low for Relay Therapeutics Inc stock?
The Relay Therapeutics Inc 52-week low stock price is $2.98.
Can I buy RLAY shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy RLAY shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in RLAY on Stake
- Buy RLAY from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of RLAY from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
RLAY related stocks